The 11th International AIDS Society Conference on HIV Science

Leia os resumos feitos pelos membros especialistas do painel sobre os principais estudos desta importante conferência anual, incluindo novos dados sobre os seguintes temas atuais: PrEP do VIH; tratamento ART com dois medicamentos combinados; ART em crianças e adolescentes; ART de longa duração; ART experimental; estratégias de tratamento para a meningite criptocócica e para a tuberculose resistente a medicamentos; e resultados da COVID-19 em pacientes com VIH.

Daniel R. Kuritzkes, MD Chloe Orkin, MBChB, FRCP, MD Babafemi Taiwo, MBBS Released: August 30, 2021

Podrá leer resúmenes de miembros expertos del panel sobre los estudios principales de esta importante conferencia anual, incluidos nuevos datos sobre los siguientes temas candentes: PrEP del VIH; régimen TAR de 2 fármacos, TAR en niños y adolescentes, TAR de larga duración, TAR experimental, estrategias de tratamiento para la meningitis criptocócica y la tuberculosis resistente a los fármacos, y resultados de la COVID-19 en pacientes con VIH.

Daniel R. Kuritzkes, MD Chloe Orkin, MBChB, FRCP, MD Babafemi Taiwo, MBBS Released: August 30, 2021

Read my take on new Eastern European studies from IAS 2021 on improving HIV services, innovative methods for HIV prevention during COVID-19, outreach programs, and more.

Deniz Gökengin, MD Released: September 1, 2021

Here’s why I think we can be reassured by the multinational SALSA study findings, which demonstrated noninferior virologic efficacy of switching vs continuing various 3-drug or 4-drug regimens.

Josep M. Llibre, MD, PhD Released: August 23, 2021

My key takeaways on data presented from 2 prevention studies at IAS 2021, including Internet-based survey results about long-acting injectable PrEP among American MSM and oral monthly islatravir.

Darrell H. S. Tan, MD, FRCPC, PhD Released: August 18, 2021

Mes principales conclusions sur les données présentées dans le cadre de deux études de prévention lors de l'IAS 2021, y compris les résultats d'un sondage sur Internet concernant la PrEP injectable à action prolongée chez les HSH américains et l'Islatravir oral à usage mensuel.

In this commentary, find out why I think studies on ARV-associated weight gain and long-acting ART are important for the treatment landscape in Australia.

Prof. Don Smith Released: August 18, 2021

My insights from Latin America on the results of the AMBITION-cm trial using single, high dose of liposomal Amphotericin B vs standard therapy for cryptococcal meningitis.

Pedro Cahn, MD, PhD Released: August 20, 2021

Could liposomal amphotericin B (LAmB) be useful in patients with elevated intracranial pressure (ICP)? Here are my thoughts based on the AMBITION-cm study presented at IAS.

Chien-Ching Hung, MD, PhD Released: September 2, 2021

My perspectives on how LA CAB/RPV and liposomal amphotericin B have unique considerations for people with HIV in Africa.

Babafemi Taiwo, MBBS Released: September 17, 2021